RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
IDEXX Laboratories Stock

IDEXX Laboratories P/S 2024

IDEXX Laboratories P/S

10.35

Ticker

IDXX

ISIN

US45168D1046

WKN

888210

As of Oct 4, 2024, IDEXX Laboratories's P/S ratio stood at 10.35, a -3.99% change from the 10.78 P/S ratio recorded in the previous year.

The IDEXX Laboratories P/S history

IDEXX Laboratories Aktienanalyse

What does IDEXX Laboratories do?

The history of IDEXX Laboratories Inc began in 1983 when a research team from the University of Maine developed technology for the automatic analysis of animal blood. The first products were soon sold and the company grew rapidly. Today, IDEXX is a leading global provider of veterinary diagnostic and IT solutions, recognized by customers in over 175 countries. IDEXX's business model is based on innovation and a comprehensive understanding of the needs of veterinarians and their patients. The company offers a wide range of products and solutions that make the diagnosis and treatment of animal diseases easier and more reliable. These include tests and devices for blood analysis, urine and stool diagnostics, as well as imaging, infection control, and cancer diagnostics. The company has several divisions that focus on different aspects of veterinary diagnostics. IDEXX Diagnostics is the largest business segment, offering veterinary lab services, diagnostic tests, and software solutions. IDEXX Water is a company specializing in the analysis of water samples and monitoring of environmental conditions. IDEXX Livestock, the newest division of IDEXX, provides veterinary solutions for agricultural and livestock operations. Key products of IDEXX include tests for parasites, infections, diabetes, and kidney function. The company has also developed some innovative products, such as SNAP tests, which provide fast and accurate results and can perform tests for various pathogens simultaneously. IDEXX is also a company committed to sustainability. The IDEXX Foundation was established in 2013 and has since donated over $32 million to local and global projects that aim to protect animals and the environment. Overall, IDEXX Laboratories Inc is a company specialized in veterinary diagnostic and IT solutions to support veterinarians in treating animals. The wide range of solutions and products, as well as the commitment to sustainability, make the company an important player in the market for veterinary diagnostics. IDEXX Laboratories ist eines der beliebtesten Unternehmen auf Eulerpool.com.

IDEXX Laboratories revenue by segment

In the annual report of the IDEXX Laboratories share (US45168D1046, 888210, IDXX), it breaks down its revenues into 4 segments: 1. Companion Animal Group, 2. Water, 3. Livestock, Poultry & Dairy, 4. Other. The IDEXX Laboratories stock (WKN: 888210, ISIN: US45168D1046, Ticker Symbol: IDXX) is a leading investment for investors interested in participating in the Health Care sector.

  • 88 % Companion Animal Group

  • 6 % Water

  • 5 % Livestock, Poultry & Dairy

  • 1 % Other

P/S Details

Decoding IDEXX Laboratories's P/S Ratio

IDEXX Laboratories's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing IDEXX Laboratories's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating IDEXX Laboratories's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in IDEXX Laboratories’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about IDEXX Laboratories stock

What is the price-to-earnings ratio of IDEXX Laboratories?

The price-earnings ratio of IDEXX Laboratories is currently 10.35.

How has the price-earnings ratio of IDEXX Laboratories changed compared to last year?

The price-to-earnings ratio of IDEXX Laboratories has increased by -3.99% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of IDEXX Laboratories high compared to other companies?

Yes, the price-to-earnings ratio of IDEXX Laboratories is high compared to other companies.

How does an increase in the price-earnings ratio of IDEXX Laboratories affect the company?

An increase in the price-earnings ratio of IDEXX Laboratories would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of IDEXX Laboratories affect the company?

A decrease in the price-earnings ratio of IDEXX Laboratories would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of IDEXX Laboratories?

Some factors that influence the price-earnings ratio of IDEXX Laboratories are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does IDEXX Laboratories pay?

Over the past 12 months, IDEXX Laboratories paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, IDEXX Laboratories is expected to pay a dividend of 0 USD.

What is the dividend yield of IDEXX Laboratories?

The current dividend yield of IDEXX Laboratories is .

When does IDEXX Laboratories pay dividends?

IDEXX Laboratories pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of IDEXX Laboratories?

IDEXX Laboratories paid dividends every year for the past 0 years.

What is the dividend of IDEXX Laboratories?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is IDEXX Laboratories located?

IDEXX Laboratories is assigned to the 'Health' sector.

Wann musste ich die Aktien von IDEXX Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of IDEXX Laboratories from 10/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/4/2024.

When did IDEXX Laboratories pay the last dividend?

The last dividend was paid out on 10/4/2024.

What was the dividend of IDEXX Laboratories in the year 2023?

In the year 2023, IDEXX Laboratories distributed 0 USD as dividends.

In which currency does IDEXX Laboratories pay out the dividend?

The dividends of IDEXX Laboratories are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The IDEXX Laboratories stock can be added to a savings plan with the following providers: Trade Republic and Consorsbank

Andere Kennzahlen von IDEXX Laboratories

Our stock analysis for IDEXX Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of IDEXX Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.